Earn CME: https://naccme.com/program/7317
In this presentation from the ‘Evaluating the Role of PI3K Inhibitors in Follicular Lymphoma: Highlighting the Diversity and Impact of an Emerging Therapeutic Class symposium, Dr. Peter Martin provides an overview of how to approach early relapsing follicular lymphoma.
© 2018 Imedex, an HMP Company
Advertisement